Evaxion CEO Departs; CFO and Interim CEO Appointed

Dow Jones
07/01
 

By Denny Jacob

 

Evaxion said Chief Executive Christian Kanstrup has stepped down and that a search for its next leader is under way.

The clinical-stage tech-bio company said Chief Scientific Officer Birgitte Rønø was appointed interim CEO. Rønø has been with Evaxion since 2017 and joined its executive management in 2021.

Additionally, Thomas Schmidt was named permanent chief financial officer after joining the company in November as interim CFO.

 

Write to Denny Jacob at denny.jacob@wsj.com

 

(END) Dow Jones Newswires

July 01, 2025 08:46 ET (12:46 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10